These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20308629)

  • 1. IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction.
    Stirnweiss A; Ksienzyk A; Klages K; Rand U; Grashoff M; Hauser H; Kröger A
    J Immunol; 2010 May; 184(9):5179-85. PubMed ID: 20308629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.
    Matsuyama T; Kimura T; Kitagawa M; Pfeffer K; Kawakami T; Watanabe N; Kündig TM; Amakawa R; Kishihara K; Wakeham A
    Cell; 1993 Oct; 75(1):83-97. PubMed ID: 8402903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.
    Yoneyama M; Suhara W; Fukuhara Y; Fukuda M; Nishida E; Fujita T
    EMBO J; 1998 Feb; 17(4):1087-95. PubMed ID: 9463386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus.
    Hata N; Sato M; Takaoka A; Asagiri M; Tanaka N; Taniguchi T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):518-25. PubMed ID: 11444873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRF-7 is the master regulator of type-I interferon-dependent immune responses.
    Honda K; Yanai H; Negishi H; Asagiri M; Sato M; Mizutani T; Shimada N; Ohba Y; Takaoka A; Yoshida N; Taniguchi T
    Nature; 2005 Apr; 434(7034):772-7. PubMed ID: 15800576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells.
    Galon J; Sudarshan C; Ito S; Finbloom D; O'Shea JJ
    J Immunol; 1999 Jun; 162(12):7256-62. PubMed ID: 10358173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y; Rohn WM; Benveniste EN
    J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational control of the innate immune response through IRF-7.
    Colina R; Costa-Mattioli M; Dowling RJ; Jaramillo M; Tai LH; Breitbach CJ; Martineau Y; Larsson O; Rong L; Svitkin YV; Makrigiannis AP; Bell JC; Sonenberg N
    Nature; 2008 Mar; 452(7185):323-8. PubMed ID: 18272964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
    Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
    J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17beta-estradiol downregulates interferon regulatory factor-1 in murine splenocytes.
    Lengi AJ; Phillips RA; Karpuzoglu E; Ahmed SA
    J Mol Endocrinol; 2006 Dec; 37(3):421-32. PubMed ID: 17170083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process.
    Molle C; Goldman M; Goriely S
    J Immunol; 2010 Feb; 184(4):1784-92. PubMed ID: 20083668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation.
    Sgarbanti M; Marsili G; Remoli AL; Ridolfi B; Stellacci E; Borsetti A; Ensoli B; Battistini A
    Ann N Y Acad Sci; 2004 Dec; 1030():187-95. PubMed ID: 15659797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells.
    Schmitz F; Heit A; Guggemoos S; Krug A; Mages J; Schiemann M; Adler H; Drexler I; Haas T; Lang R; Wagner H
    Eur J Immunol; 2007 Feb; 37(2):315-27. PubMed ID: 17273999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to virus infection is determined by a Stat-mediated response to the autocrine effect of virus-induced type I interferon.
    Improta T; Pine R
    Cytokine; 1997 Jun; 9(6):383-93. PubMed ID: 9199872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1.
    Fujita T; Kimura Y; Miyamoto M; Barsoumian EL; Taniguchi T
    Nature; 1989 Jan; 337(6204):270-2. PubMed ID: 2911367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.
    Saitoh T; Satoh T; Yamamoto N; Uematsu S; Takeuchi O; Kawai T; Akira S
    Immunity; 2011 Mar; 34(3):352-63. PubMed ID: 21435586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.
    Goenka S; Youn J; Dzurek LM; Schindler U; Yu-Lee LY; Boothby M
    J Immunol; 1999 Nov; 163(9):4663-72. PubMed ID: 10528163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important role of interferon regulatory factor (IRF)-3 in the interferon response of mouse macrophages upon infection by Newcastle disease virus.
    Wilden H; Schirrmacher V; Fournier P
    Int J Oncol; 2011 Aug; 39(2):493-504. PubMed ID: 21567079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.